0001127602-17-022382.txt : 20170629
0001127602-17-022382.hdr.sgml : 20170629
20170629171030
ACCESSION NUMBER: 0001127602-17-022382
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170628
FILED AS OF DATE: 20170629
DATE AS OF CHANGE: 20170629
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bioverativ Inc.
CENTRAL INDEX KEY: 0001681689
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813461310
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 2ND AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-663-4400
MAIL ADDRESS:
STREET 1: 225 2ND AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duvall Diantha
CENTRAL INDEX KEY: 0001696784
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37859
FILM NUMBER: 17939357
MAIL ADDRESS:
STREET 1: BIOVERATIV INC.
STREET 2: 225 SECOND AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-06-28
0001681689
Bioverativ Inc.
BIVV
0001696784
Duvall Diantha
225 2ND AVENUE
WALTHAM
MA
02451
1
Chief Accounting Officer
Common Stock
2017-06-28
4
S
0
818
60.47
D
2128
D
Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
/s/ Matthew S. Gilman, attorney-in-fact for Diantha Duvall
2017-06-29